Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

Rheumatology abstract feed lacks clinical data for rewrite

The scraped entry contains only copyright boilerplate and no abstract text, leaving no endpoints, cohort data, or results to assess.

By Dr. A. Nikhil Krishnan, MBBS · Oct 22, 2026 · 4 min read

Rheumatology·ARD

SSc-ILD severity definitions remain inconsistent across studies

A systematic review found wide heterogeneity in how SSc-ILD severity and progression are defined, reinforcing the need for…

Oct 22, 2026

Rheumatology·ARD

Topical Glyceryl Trinitrate Studied for Skin Perfusion in Scleroderma

A controlled trial examined topical glyceryl trinitrate for skin blood flow and elasticity in scleroderma, targeting the microvascular…

Oct 21, 2026

Rheumatology·ARD

sJADAS10 Validated in Adults With Still’s Disease

Adult Still's disease visits showed strong agreement between sJADAS10 and Rosina activity states, supporting cross-age disease assessment.

Oct 21, 2026

Rheumatology·Br J Cancer

Knee Osteoarthritis Therapies Expand Beyond Pain Relief and Injections

A 2026 review maps new knee osteoarthritis therapies, from semaglutide to gene therapy, and explains why disease-modifying drugs…

Oct 21, 2026

Rheumatology·ARD

EULAR 2025 rheumatoid arthritis recommendations update DMARD sequencing

EULAR’s 2025 update refines rheumatoid arthritis treatment with MTX-first sequencing, biologic escalation, JAK inhibitor cautions, and tapering guidance.

Oct 21, 2026

Rheumatology·DailyMed

Tofacitinib Label Expands Warnings on Infection, MACE and Thrombosis

Updated tofacitinib labeling adds boxed-warning emphasis on infection, mortality, malignancy, MACE, thrombosis, plus revised dosing and monitoring guidance.

Oct 21, 2026

Rheumatology·ARD